PEOPLE > Scientists
Sen Laboratory>Sabyasachi Sen, M.D., M.R.C.P., Ph.D. Telephone: 413.794.0522 Physician, Endocrinology and Metabolism, Baystate Education M.D., R.G. Kar Medical College, Calcutta University, India Membership of The Royal College of Physicians in London Postdoctoral Experience Doctorate of Medicine, Department of Medicine, National University of Ireland St. Elizabeth's Medical Center, Tufts University, 2003-2005, Internal Medicine Residency NIDDK, NIH, Clinical and Research Endocrinology, Diabetes and Metabolism 2005-2008 Fellowship ABIM CERTIFIED - Internal Medicine |
|
Research Interests My laboratory studies adult stem cell survival and differentiation. Adult mesenchymal stem cells (MSCs) are the building blocks of our body. These cells act as repair and regenerative cells to replace old and dying cells. During the course of repair and regeneration, MSCs develop in ways that can maintain health or lead to clinical problems such as osteoporosis and cardiovascular disease, both of which are more likely to occur in people with diabetes. In certain environments within the body these cells can be induced to differentiate into fat, bone, cartilage or muscle, and the goal of my research program is to modify these cell environments so that MSCs differentiate into beneficial cell types like bone or muscle rather than fat. As part of this research, we are learning how to harness the potent growth factors secreted by endothelial progenitor stem cells (EPCs), another adult stem cell type, to help coax MSCs to grow, survive and differentiate to maintain health and prevent diseases by secreting growth factors. We are using human mesenchymal stem cells from different sources such as bone marrow, adipose tissue and pancreatic islets and modifying the environment to address patho-physilogy of disease states such as diabetes and obesity. Working Groups:
Selected papers: Sen S, Conroy S, Hynes S, McMahon J, O’Doherty A, Bartlett J, Akhtar Y, Adegbola T, Connolly C, Sultan S, Barry F, Katusic Z, O’Brien T: Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5. 2008 Fed; 10(2):143-51. J Gene Med. Sen S, Strappe P, O’Brien T: Gene transfer in endothelial dysfunction and hypertension. Methods Mol Med. 2005; 108:299-314. Review Sumner A, Sen S, Ricks M, Frempong B, Sebring N, Kushner H: Determining the waist circumference in African Americans which best predicts insulin resistance. Obesity (Silver Spring). 2008; 16(4):841-845. Sen, S; Dean, J; Silver, M, et al: Adeno-associated virus mediated transduction of endothelial progenitor cells, Circulation 2005, Vol.: 112 Issue: 17 Pages: U94-U94 Dobrucki L, Tsutsumi Y., Sen S, Aikawa R et al: Analysis of angiogenesis induced by local IGF-1 gene delivery after myocardial infarction: Application and Validation of integrin targeted imaging by SPECT-CT: Accepted by American Journal of Physiology - Heart and Circulatory Physiology- June 2009 Sen S, Yadava N, Gershengorn MC: Human Endothelial Progenitor Cell-Conditioned Media Improves Survival and Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells (hMSCs) ATVB, July 2009, Vol.29 Issue: 7: E53-E53 |

